175 related articles for article (PubMed ID: 308545)
1. BN rat myeloid leukemia transferred to the (LEW x BN)F1 rat.
Vaughn WP; Burke PJ; Jung J
J Natl Cancer Inst; 1978 Sep; 61(3):927-9. PubMed ID: 308545
[TBL] [Abstract][Full Text] [Related]
2. Drug induced host factors which stimulate growth of residual leukemia in Lewis x Brown Norway F1 (LEW-BN) rats.
Burke PJ; Karp JE; Saylor PL
Cancer Res; 1986 Apr; 46(4 Pt 1):1813-6. PubMed ID: 3485014
[TBL] [Abstract][Full Text] [Related]
3. Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat model.
Vaughan WP; Burke PJ
Cancer Res; 1983 May; 43(5):2005-9. PubMed ID: 6572561
[TBL] [Abstract][Full Text] [Related]
4. In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia.
van Bekkum DW; van Oosterom P; Dicke KA
Cancer Res; 1976 Mar; 36(3):941-6. PubMed ID: 1062232
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of a rat model for human acute myelocytic leukemia.
Hagenbeek A; Martens AC
Haematologica; 1980 Jun; 65(3):293-308. PubMed ID: 6778781
[No Abstract] [Full Text] [Related]
6. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
Wegmann KW; Hinrichs DJ
J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
[TBL] [Abstract][Full Text] [Related]
7. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
[TBL] [Abstract][Full Text] [Related]
8. A subline of the Brown Norway myeloid leukemia in the Lewis x Brown Norway rat: in vivo growth characteristics and development of an in vitro clonogenic assay.
Wiley JM; Yeager AM; Johnson RJ; Lanotte M
Int J Cell Cloning; 1989 Sep; 7(5):292-302. PubMed ID: 2788672
[TBL] [Abstract][Full Text] [Related]
9. Absence of transplantation tolerance and strong sensitization in the host after transplantation of spleen allografts in the (LEW X BN)F1 leads to lew strain combination.
Gugenheim J; Charpentier B; Houssin D; Martin B; Martin E; Fries D; Bismuth H
Transplantation; 1983 Oct; 36(4):470-1. PubMed ID: 6226138
[No Abstract] [Full Text] [Related]
10. F1 hybrid resistance to BN rat myelogenous leukemia parallels resistance to transplantation of normal BN bone marrow.
Williams RM; Singer DE; Rodday P; Bennett M
Leuk Res; 1980; 4(2):261-4. PubMed ID: 6997635
[No Abstract] [Full Text] [Related]
11. Role of non-RT1 genes in the response of rat lymphocytes to Mycoplasma arthritidis T cell mitogen, concanavalin A and phytohemagglutinin.
Cole BC; Griffiths MM; Sullivan GJ; Ward JR
J Immunol; 1986 Apr; 136(7):2364-9. PubMed ID: 3081642
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of leukemia growth in a rat model using a highly sensitive assay for the detection of LacZ marked leukemic cells.
Hendrikx PJ; Martens AC; Schultz FW; Visser JW; Hagenbeek A
Leukemia; 1995 Nov; 9(11):1954-60. PubMed ID: 7475289
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of retinyl palmitate and cytarabine treatment in a slowly growing rat leukemia model.
Wathne KO; Lie SO; Colly L
In Vivo; 1988; 2(2):139-41. PubMed ID: 2979829
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.
Tutschka PJ; Berkowitz SD; Tuttle S; Klein J
Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945
[No Abstract] [Full Text] [Related]
15. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
Burke PJ; Karp JE; Vaughan WP
J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525
[TBL] [Abstract][Full Text] [Related]
16. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
[TBL] [Abstract][Full Text] [Related]
17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
18. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
Majoor GD; Van Breda Vriesman PJ
Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an acute graft-versus-host disease model following liver transplantation in donor-dominant one-way major histocompatibility complex matching rats.
Xue F; Chen W; Wang XG; Liang L; Bai XL; Wang LY; Wang HP; Liang TB
Transplant Proc; 2009 Jun; 41(5):1914-20. PubMed ID: 19545756
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD).
Yan Y; Martens AC; de Groot CJ; Hendrikx PJ; Valerio D; van Bekkum DW; Hagenbeek A
Leukemia; 1993 Jan; 7(1):131-9. PubMed ID: 8418372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
